A senior executive at Baxter International recently pointed out that the company’s first-quarter business still faces ongoing challenges caused by the return of Novum infusion devices.
Show original
Despite the measures taken, fluctuations in market acceptance of this product continue to cast a shadow over performance. Meanwhile, uncertainty in customer purchasing behavior persists. Medical institutions are showing a more cautious attitude in their equipment procurement decisions, a trend that may directly impact Baxter International's short-term revenue. Industry observers believe that the medical device sector is undergoing a structural adjustment in supply and demand relationships.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trump Media & Technology Group shares rose 1.7% in pre-market trading
老虎证券•2026/02/27 14:24
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$66,054.49
-2.81%
Ethereum
ETH
$1,950.64
-5.56%
Tether USDt
USDT
$1
+0.03%
BNB
BNB
$614.05
-2.01%
XRP
XRP
$1.37
-4.80%
USDC
USDC
$1
+0.01%
Solana
SOL
$82.84
-5.64%
TRON
TRX
$0.2839
-0.96%
Dogecoin
DOGE
$0.09441
-4.53%
Cardano
ADA
$0.2826
-3.53%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now